Clinical trials
Phase 1/2 Multiple Myeloma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Completed | 7 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| Regeneron Pharmaceuticals | 3 |
| AbbVie | 2 |
| GlaxoSmithKline | 2 |
| Autolus Limited | 1 |
| BeOne Medicines | 1 |
| Bristol-Myers Squibb | 1 |
| CellCentric Ltd. | 1 |
| Chroma Therapeutics | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 24 |
| Recurrence | 7 |
| Leukemia, Myeloid, Acute | 3 |
| Neoplasms | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia | 2 |
| Myelodysplastic Syndromes | 2 |
| Blood Protein Disorders | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.